Status:
UNKNOWN
Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive Patients
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Collaborating Sponsors:
Instituto de Información e Investigación en Salud Mental A. C.
Conditions:
Major Depressive Disorder
Anxiety Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The objective of this transversal study is to determine if there is a difference in the volume of the hippocampus with the degree of anxiety.
Eligibility Criteria
Inclusion
- First-time patients, without prior antidepressant treatment that meet the diagnostic criteria of DSM 5 for major depressive disorder.
- Patients who meet the current major depressive disorder criteria in the MINI interview.
- Patients who signed the informed consent for the investigation.
Exclusion
- Patients presenting insufficient data in the MINI interview for current major depression.
- Patients diagnosed with intellectual development disorder, by clinic.
- Patients with diagnosis of the schizophrenic spectrum, bipolar disorder, autism spectrum disorder, post-traumatic stress disorder and obsessive-compulsive disorder by clinic and / or by the MINI interview.
- Patients with contraindications for MRI.
- Patients with serious or unstable medical problems.
- Patients undergoing some legal procedure.
- Patients with difficulties in understanding the interview or completing the assessment instruments.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04430556
Start Date
July 1 2018
End Date
December 1 2020
Last Update
June 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Dr. Jose E. Gonzalez
Monterrey, Nuevo León, Mexico, 64460